Bharat Biotech Releases Covaxin's Price Ahead Of India's Phase 3 Of Vaccination | Covid-19 Vaccine

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination | COVID-19 Vaccine

WION

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination | COVID-19 Vaccine

Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy

NDTV

Bharat Biotech Phase 3 Results | Covaxin releases their interim analysis from phase three trials

Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%| Breaking

Bharat Biotech's Covaxin Shows 77.8% Efficacy Rate In Phase 3 Trial

Covid-19 Vaccine: Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 Data

NDTV

COVID19 Vaccine | Bharat Biotech's Covaxin shows 77.8% efficacy in Phase 3 trials

The New Indian Express

Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial

NDTV

Bharat Biotech Concludes Phase 3 trial Of Covaxin Records 77.8% Efficacy Rate

Phase III Trials Of Bharat Biotech's Covaxin | CNBC-TV18

Covaxin: Bharat Biotech Granted Permission To Start Phase-3 Trials For Covid-19 Vaccine

How Bharat Biotech’s COVID- 19 Vaccine Works/India's First indigenous COVID-19 Vaccine

Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech

NDTV

Bharat Biotech’s ‘Covaxin’ enters phase 3 trials

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News

COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By DCGI

Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under Review

How effective is India's Covaxin again COVID and Delta | Here's what the numbers reveal

Bharat Biotech’s Covaxin shows 81% efficacy in Phase 3 Clinical trials

NETWORK 7 MEDIA GROUP